HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells.

Abstract
Ovarian cancer is the first cause of death for gynecological malignances in developed countries and around 80% correspond to Epithelial Ovarian Cancer (EOC). Overexpression of Nerve Growth Factor (NGF) and its high affinity receptor TRKA are involved in EOC progression, modulating several oncogenic processes such as angiogenesis by the increase of Vascular Endothelial Growth Factor (VEGF). FSH receptors (FSH-R) are present in EOC, but their changes and contribution during EOC progression are still not thoroughly known. The aims of this study were to evaluate the abundance of FSH receptors during EOC differentiation and to determine whether FSH modulates oncoproteins such as NGF and VEGF in ovarian cells. FSH-R expression in EOC tissues and cell lines (A2780, poorly differentiated EOC cells and HOSE, non-tumoral ovarian surface epithelial cells) were measured by RT-PCR and laser capture of epithelial cells from EOC samples by qPCR. FSH-R protein levels were evaluated by immunohisto/cytochemistry. Additionally, ovarian explants and ovarian cell lines were stimulated with FSH and/or FSH-R inhibitor to assess NGF and VEGF mRNA and protein levels. The results showed that FSH-R levels decreased during EOC progression, nevertheless these receptors are still present in poorly differentiated EOC. FSH increased NGF expression in ovarian cells, which was prevented using a FSH-R inhibitor. Similarly, in ovarian cancer explants, FSH increased NGF and VEGF mRNA, as well as NGF protein levels. These results suggest that FSH would display a key role not only in initial stages of EOC, but also in late stages of this disease, by modulation of NGF and VEGF levels in EOC cells.
AuthorsMaritza P Garrido, Nicole Bruneau, Margarita Vega, Alberto Selman, Julio C Tapia, Carmen Romero
JournalHistology and histopathology (Histol Histopathol) Vol. 35 Issue 9 Pg. 961-971 (Sep 2020) ISSN: 1699-5848 [Electronic] Spain
PMID32369181 (Publication Type: Journal Article)
Chemical References
  • Receptors, FSH
  • Vascular Endothelial Growth Factor A
  • Follicle Stimulating Hormone
  • Nerve Growth Factor
Topics
  • Cell Line
  • Cystadenocarcinoma, Serous (metabolism, pathology)
  • Epithelial Cells (drug effects, metabolism)
  • Female
  • Follicle Stimulating Hormone (pharmacology)
  • Humans
  • Nerve Growth Factor (metabolism)
  • Ovarian Neoplasms (metabolism, pathology)
  • Ovary (drug effects, metabolism)
  • Receptors, FSH (metabolism)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: